These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

744 related items for PubMed ID: 18049333

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Recognition of Epstein-Barr virus (EBV)-infected cells by T cell colonies from a human chimera: restriction by allogeneic determinants.
    Plotnicky H, Touraine JL.
    Clin Exp Immunol; 1993 Dec; 94(3):494-9. PubMed ID: 7504600
    [Abstract] [Full Text] [Related]

  • 23. Epstein-Barr virus-transformed B-cells as efficient antigen presenting cells to propagate Aspergillus-specific cytotoxic T-lymphocytes.
    Ramadan G.
    Egypt J Immunol; 2008 Dec; 15(1):145-57. PubMed ID: 20306679
    [Abstract] [Full Text] [Related]

  • 24. Epstein-Barr virus (EBV) latent membrane protein-1-specific cytotoxic T lymphocytes targeting EBV-carrying natural killer cell malignancies.
    Demachi-Okamura A, Ito Y, Akatsuka Y, Tsujimura K, Morishima Y, Takahashi T, Kuzushima K.
    Eur J Immunol; 2006 Mar; 36(3):593-602. PubMed ID: 16479544
    [Abstract] [Full Text] [Related]

  • 25. Robust expansion of viral antigen-specific CD4+ and CD8+ T cells for adoptive T cell therapy using gene-modified activated T cells as antigen presenting cells.
    Melenhorst JJ, Solomon SR, Shenoy A, Hensel NF, McCoy JP, Keyvanfar K, Barrett AJ.
    J Immunother; 2006 Mar; 29(4):436-43; discussion 365-6. PubMed ID: 16799339
    [Abstract] [Full Text] [Related]

  • 26. Augmentation of virus-specific immunity after hematopoietic stem cell transplantation by adoptive T-cell therapy.
    Peggs KS, Mackinnon S.
    Hum Immunol; 2004 May; 65(5):550-7. PubMed ID: 15172456
    [Abstract] [Full Text] [Related]

  • 27. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
    Chen HW, Liao CH, Ying C, Chang CJ, Lin CM.
    Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
    [Abstract] [Full Text] [Related]

  • 28. Assessment and characterization of the cytolytic T lymphocyte response against Epstein-Barr virus in patients with non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantation.
    Nolte A, Buhmann R, Straka C, Emmerich B, Hallek M.
    Bone Marrow Transplant; 1998 May; 21(9):909-16. PubMed ID: 9613783
    [Abstract] [Full Text] [Related]

  • 29. CD4(+) Epstein-Barr virus-specific cytotoxic T-lymphocytes from human umbilical cord blood.
    Sun Q, Burton RL, Pollok KE, Emanuel DJ, Lucas KG.
    Cell Immunol; 1999 Aug 01; 195(2):81-8. PubMed ID: 10448007
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Expansion of peripheral CD8+ CD28- T cells in response to Epstein-Barr virus in patients with rheumatoid arthritis.
    Klatt T, Ouyang Q, Flad T, Koetter I, Bühring HJ, Kalbacher H, Pawelec G, Müller CA.
    J Rheumatol; 2005 Feb 01; 32(2):239-51. PubMed ID: 15693083
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Novel method for detection of virus-specific CD41+ T cells indicates a decreased EBV-specific CD4+ T cell response in untreated HIV-infected subjects.
    Piriou ER, van Dort K, Nanlohy NM, van Oers MH, Miedema F, van Baarle D.
    Eur J Immunol; 2005 Mar 01; 35(3):796-805. PubMed ID: 15724243
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Ex vivo generation of cytokine-induced killer cells (CD3+ CD56+) from post-stem cell transplant pediatric patients against autologous-Epstein-Barr virus-transformed lymphoblastoid cell lines.
    Petvises S, Pakakasama S, Wongkajornsilp A, Sirireung S, Panthangkool W, Hongeng S.
    Pediatr Transplant; 2007 Aug 01; 11(5):511-7. PubMed ID: 17631019
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Human T-cell leukemia virus type-I (HTLV-I)-specific T-cell responses detected using three-divided glutathione-S-transferase (GST)-Tax fusion proteins.
    Kurihara K, Shimizu Y, Takamori A, Harashima N, Noji M, Masuda T, Utsunomiya A, Okamura J, Kannagi M.
    J Immunol Methods; 2006 Jun 30; 313(1-2):61-73. PubMed ID: 16723135
    [Abstract] [Full Text] [Related]

  • 40. Rapid expansion of tumor-reactive cells from HLA-matched siblings for adoptive immunotherapy of melanoma.
    Gottlieb DJ, Micklethwaite K, Bradstock KF, Li YC.
    Cytotherapy; 2007 Jun 30; 9(2):133-43. PubMed ID: 17453965
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 38.